Shared Decision-Making Intervention for Gestational Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines whether a shared decision-making approach with pharmacists can help women who have had gestational diabetes (a type of diabetes that occurs during pregnancy) better manage their weight and reduce their risk of developing type 2 diabetes. The trial includes two groups: one will receive the shared decision-making intervention, and the other will receive usual care. Women who have had gestational diabetes, experienced prediabetes in the last three years, and are dealing with weight issues might be a good fit for this study. As an unphased trial, this study offers participants the opportunity to contribute to innovative research that could improve future care for women facing similar health challenges.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you have used anti-glycemic medications in the past 12 months.
What prior data suggests that this shared decision-making intervention is safe for diabetes prevention?
Research has shown that shared decision-making for preventing diabetes is generally well-received. Studies have found that this approach helps women who have had gestational diabetes (a type of diabetes during pregnancy) make informed health choices.
These studies have not identified any serious side effects from shared decision-making itself. Instead, they emphasize how this method can empower patients to lead healthier lives, reducing their risk of developing type 2 diabetes.
In summary, shared decision-making for diabetes prevention appears safe and has been successfully used to support better health decisions.12345Why are researchers excited about this trial?
Researchers are excited about this shared decision-making intervention for gestational diabetes because it empowers patients by involving them directly in their diabetes care alongside pharmacists. Unlike standard care, which primarily involves routine check-ups and general guidance, this approach focuses on personalized care plans and active collaboration between patients and healthcare providers. By integrating pharmacists into the decision-making process, this method aims to improve adherence to prevention strategies and enhance patient outcomes, offering a more tailored and engaging way to manage gestational diabetes risk.
What evidence suggests that shared decision-making for diabetes prevention is effective for women with a history of gestational diabetes?
Research shows that shared decision-making (SDM) can assist women who had gestational diabetes (GDM) and are at risk of developing type 2 diabetes. Studies have found that SDM increases awareness of choices and encourages adherence to healthy habits to prevent diabetes. For instance, SDM can lead to better weight loss and the use of proven methods to reduce diabetes risk. In this trial, participants in the intervention arm will engage in SDM with pharmacists, which studies have shown improves outcomes, such as planning exercise for women with GDM. This approach involves working closely with healthcare providers to make informed decisions that fit individual needs.12367
Who Is on the Research Team?
Kenrik Duru, MD,MSHS
Principal Investigator
University of California, Los Angeles
Tannaz Moin, MD,MBA,MSHS
Principal Investigator
University of California, Los Angeles
Are You a Good Fit for This Trial?
This trial is for women who had gestational diabetes and are at risk of type 2 diabetes. They should have a BMI of 25 or higher (23 if Asian American), recent signs of prediabetes, and be part of the UCLA or Intermountain Healthcare Systems. Women can't join if they've had bariatric surgery recently, use anti-glycemic meds, are currently pregnant, or have severe kidney issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a baseline survey and have their weight recorded
Intervention
Participants receive a pharmacist-coordinated shared decision making intervention
Follow-up
Participants are monitored for weight change and uptake of lifestyle changes or metformin use
What Are the Treatments Tested in This Trial?
Interventions
- Shared decision-making for diabetes prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Intermountain Health Care, Inc.
Collaborator